Xi M. Tang
Jingzhou, 434000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Recombinant human endostatin injection (Endostar) combined with PF chemotherapy and sequential intensity-modulated radiotherapy is tolerable and improves prognosis of locally advanced nasopharyngeal carcinoma: a randomized, open, multicenter phase II clinical study.
Journal: American journal of cancer research
Published: May 04, 2022
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Journal: The oncologist
Published: May 28, 2020
Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy.
Journal: Annals of translational medicine
Published: December 01, 2018
Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Journal: Journal of computer assisted tomography
Published: April 04, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy vs Concurrent Chemoradiotherapy in Elderly Patients with Advanced Nasopharyngeal Carcinoma.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: April 19, 2017
Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.
Journal: Clinical lung cancer
Published: June 16, 2015
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.
Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 13, 2012
MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.
Journal: The American journal of pathology
Published: June 10, 2011
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 22, 2010
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 19, 2009
Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.
Journal: Molecular cancer therapeutics
Published: October 05, 2007
Last Updated: 09/26/2026